NIB Holdings Ltd (ASX: NHF) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
NIB Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
NIB Holdings Ltd (ASX: NHF)
Latest News
Earnings Results
Experts forecast the ASX 200 winners and losers this earnings season
Healthcare Shares
3 reasons why I think NIB shares could still be a buy
Broker Notes
3 ASX 200 shares just upgraded by top brokers
Healthcare Shares
4 things to look for when buying ASX healthcare shares
Share Market News
Here are the top 10 ASX 200 shares today
Financial Shares
Why this top broker says buy NIB shares over Medibank
Healthcare Shares
NIB shares are up 19% in 6 months. Here’s why Scott Phillips says it’s not too late to buy
Share Market News
Records tumble! 10 ASX 200 shares smashing new 52-week highs on Friday
Dividend Investing
3 sectors to find defensive ASX dividend shares
Opinions
Top ASX shares to buy in June 2023
52-Week Highs
3 ASX 200 stocks notching up new 52-week highs today
Broker Notes
Top brokers name 3 ASX shares to buy next week
Frequently Asked Questions
-
The company was established as Newcastle Industrial Benefits (NIB) Hospital Fund in 1952 to provide health insurance for workers at BHP Steelworks, Mayfield. It changed its name to NIB Health Funds Ltd in 1966.
In 2007 members voted in favour of demutualising the health fund, and in November that year, NIB became the first Australian private health insurer to list on the ASX.
-
NIB has paid out twice-yearly dividends – in April and October — every year since 2009. Its latest payout was a final dividend of 11 cents a share in October 2022.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
02 Mar 2023 | $0.1300 | 100.00% | Interim | 03 Apr 2023 |
05 Sep 2022 | $0.1100 | 100.00% | Final | 04 Oct 2022 |
03 Mar 2022 | $0.1100 | 100.00% | Interim | 04 Apr 2022 |
02 Sep 2021 | $0.1400 | 100.00% | Final | 05 Oct 2021 |
04 Mar 2021 | $0.1000 | 100.00% | Interim | 06 Apr 2021 |
03 Sep 2020 | $0.0400 | 100.00% | Final | 06 Oct 2020 |
05 Mar 2020 | $0.1000 | 100.00% | Interim | 07 Apr 2020 |
02 Sep 2019 | $0.1300 | 100.00% | Final | 30 Sep 2019 |
06 Sep 2018 | $0.1100 | 100.00% | Final | 05 Oct 2018 |
01 Mar 2018 | $0.0900 | 100.00% | Interim | 03 Apr 2018 |
07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
02 Mar 2017 | $0.0850 | 100.00% | Interim | 03 Apr 2017 |
08 Sep 2016 | $0.0900 | 100.00% | Final | 07 Oct 2016 |
02 Mar 2016 | $0.0575 | 100.00% | Interim | 01 Apr 2016 |
10 Sep 2014 | $0.0900 | 100.00% | Special Cash | 03 Oct 2014 |
10 Sep 2014 | $0.0575 | 100.00% | Final | 03 Oct 2014 |
05 Sep 2013 | $0.0500 | 100.00% | Final | 04 Oct 2013 |
04 Mar 2013 | $0.0500 | 100.00% | Interim | 05 Apr 2013 |
05 Mar 2012 | $0.0425 | 100.00% | Interim | 05 Apr 2012 |
07 Mar 2011 | $0.0400 | 100.00% | Interim | 08 Apr 2011 |
05 Mar 2010 | $0.0200 | 100.00% | Interim | 08 Apr 2010 |
14 Sep 2009 | $0.0440 | 100.00% | Final | 09 Oct 2009 |
NHF ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About NIB Holdings Ltd
NIB Holdings Limited (ASX: NHF) provides health and medical insurance to more than 1.5 million Australian and New Zealand residents.
In addition, it covers more than 180,000 international students and workers in Australia.
The company also offers travel insurance through its NIB Travel business, and provides health insurance plans to corporate groups through its GU Health business.
The NIB share price hit an all-time high of $8.18 on 31 August 2022.
NHF Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
09 Aug 2023 | $7.92 | $-0.08 | -1.00% | 722,886 | $7.95 | $8.00 | $7.90 |
08 Aug 2023 | $8.00 | $-0.05 | -0.62% | 1,149,311 | $8.13 | $8.15 | $7.96 |
07 Aug 2023 | $8.05 | $-0.10 | -1.23% | 412,864 | $8.13 | $8.15 | $8.03 |
04 Aug 2023 | $8.15 | $0.01 | 0.12% | 1,338,341 | $8.12 | $8.17 | $8.08 |
03 Aug 2023 | $8.14 | $0.02 | 0.25% | 609,175 | $8.11 | $8.17 | $8.08 |
02 Aug 2023 | $8.12 | $-0.11 | -1.34% | 744,408 | $8.20 | $8.23 | $8.12 |
01 Aug 2023 | $8.23 | $-0.05 | -0.60% | 468,465 | $8.28 | $8.30 | $8.23 |
31 Jul 2023 | $8.28 | $-0.07 | -0.84% | 756,530 | $8.38 | $8.40 | $8.25 |
28 Jul 2023 | $8.35 | $0.00 | 0.00% | 988,528 | $8.44 | $8.47 | $8.32 |
27 Jul 2023 | $8.35 | $-0.07 | -0.83% | 1,594,912 | $8.29 | $8.38 | $8.25 |
26 Jul 2023 | $8.42 | $0.07 | 0.84% | 757,945 | $8.37 | $8.43 | $8.32 |
25 Jul 2023 | $8.35 | $0.05 | 0.60% | 600,066 | $8.31 | $8.36 | $8.30 |
24 Jul 2023 | $8.30 | $0.08 | 0.97% | 942,820 | $8.25 | $8.32 | $8.18 |
21 Jul 2023 | $8.22 | $-0.01 | -0.12% | 767,750 | $8.26 | $8.28 | $8.16 |
20 Jul 2023 | $8.23 | $-0.02 | -0.24% | 515,857 | $8.28 | $8.29 | $8.20 |
19 Jul 2023 | $8.25 | $0.03 | 0.36% | 907,254 | $8.25 | $8.35 | $8.19 |
18 Jul 2023 | $8.22 | $0.08 | 0.98% | 802,426 | $8.29 | $8.29 | $8.17 |
17 Jul 2023 | $8.14 | $-0.15 | -1.81% | 2,275,256 | $8.19 | $8.25 | $8.01 |
14 Jul 2023 | $8.29 | $0.01 | 0.12% | 910,799 | $8.34 | $8.38 | $8.26 |
13 Jul 2023 | $8.28 | $-0.15 | -1.78% | 1,114,261 | $8.43 | $8.45 | $8.28 |
12 Jul 2023 | $8.43 | $-0.06 | -0.71% | 673,328 | $8.53 | $8.53 | $8.40 |
11 Jul 2023 | $8.49 | $0.01 | 0.12% | 659,911 | $8.60 | $8.60 | $8.48 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
21 Jun 2023 | Mark Fitzgibbon | Sell | 5 | $44,564 |
On-market trade.
|
16 Jun 2023 | Mark Fitzgibbon | Sell | 6 | $51,750 |
On-market trade.
|
15 Jun 2023 | Mark Fitzgibbon | Sell | 53 | $464,895 |
On-market trade.
|
02 Dec 2022 | Mark Fitzgibbon | Issued | 189 | $1,352,903 |
Issue of securities. 9,25,423 Performance Rights
|
20 Oct 2022 | Jacqueline Chow | Sell | 25 | $172,250 |
On-market trade.
|
21 Sep 2022 | Donal O'Dwyer | Buy | 2 | $19,000 |
On-market trade.
|
01 Sep 2022 | Mark Fitzgibbon | Expiry | 107 | $872,486 |
As advised by the company. Lapsed\7,35,675 -rights
|
01 Sep 2022 | Mark Fitzgibbon | Issued | 82 | $663,198 |
On-market trade.
|
01 Sep 2022 | Mark Fitzgibbon | Exercise | 107 | $872,486 |
Conversion of securities. 843,656 Rights
|
01 Sep 2022 | Mark Fitzgibbon | Issued | 107 | $872,486 |
Conversion of securities.
|
29 Aug 2022 | Mark Fitzgibbon | Sell | 50 | $390,381 |
On-market trade.
|
23 Aug 2022 | David Gordon | Buy | 20 | $158,600 |
On-market trade.
|
23 Aug 2022 | Peter Harmer | Buy | 8 | $65,846 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr David L Gordon | Non-Executive DirectorNon-Executive Chairman | May 2020 |
Mr Gordon has over 20 years' experience as a director of both public and private companies and has experience in the corporate advisory and financial services sector. He is currently Chair of Accent Group Limited and Founding Principal of Lexicon Partners.
|
Ms Anne Joan Loveridge | Non-Executive Director | Feb 2017 |
Ms Loveridge has over 35 years of experience in banking, wealth management, private equity and property. She has knowledge of financial and regulatory reporting, risk management controls and compliance frameworks. She also has experience as a Committee Chairperson. Formally trained as a Chartered Accountant, Anne has a of experience in financial reporting, auditing, risk, ethics and regulatory affairs following her 31 years with PwC Australia, where she retired as Partner and Deputy Chair in 2015. Through senior leadership roles in the firm, Anne also has experience and a focus on leadership, performance and culture.
|
Mr Donal Paul O'Dwyer | Non-Executive Director | Mar 2016 |
Mr O'Dwyer is also a Director of nib health funds limited. Industry experience Donal has a knowledge of the health industry globally, after more than 35 years in senior executive and Non-Executive Director roles within the healthcare products and medical device sectors. He went on to gain experience in business, science, engineering, manufacturing and management. During his tenure with Baxter Healthcare, he rose through the ranks from plant manager to President of the Cardiovascular Group Europe, gaining a understanding of the inner workings of business strategy and fiscal management, from the floor of the factory through to the boardroom.
|
Mark Fitzgibbon | Chief Executive OfficerManaging Director | May 2007 |
Mr Fitzgibbon has held executive positions at a number of large Australian organisations, including local government councils and peak bodies. Mark has previously served as CEO of both the national and NSW peak industry bodies for licensed clubs, as well as holding several General Manager positions in local government.
|
Mr Peter Harmer | Non-Executive Director | Jul 2021 |
Mr Harmer has over 40 years' experience in the Australian and international insurance and financial sectors, including over 30 years in a senior executive capacity. He was formerly Chief Executive Officer of Insurance Australia Group (IAG), CGU Insurance, Aon Limited UK, Aon Risk Services Australia Pacific and Aon Re Australia.
|
Ms Jacqueline Chow | Non-Executive Director | Apr 2018 |
Ms Chow has more than 20 years of experience working with global blue-chip consumer product multinationals in a range of executive and non-executive positions in general management, strategy, marketing as well as technology and innovation. Her early career concentrated on business analytics, brand equity and marketing. She has global experience driving strategic growth and innovation across customer and consumer brands for the likes of Fonterra, Campbell Arnott's and the Kellogg Company.
|
Mr Brad Welsh | Non-Executive Director | Jul 2023 |
Mr Welsh, who has spent more than a decade leading and advising global resource companies including Energy Resources of Australia and Rio Tinto, brings both public sector and commercial skills to his role on nibs Board. He is currently Chief Executive Officer and Managing Director at Energy Resources of Australia. Among his previous roles he was Chief Adviser to the CEO - Indigenous Affairs, at Rio Tinto; Acting General Manager, Weipa, at Rio Tinto, and worked in the Office of the NSW Premier, the Minister for Planning, and the Prime Minister of Australia.
|
Ms Jill Watts | Non-Executive Director | Jul 2023 |
Ms Watts is a Non-Executive Director on the Boards of St Vincents Healthcare, Icon Cancer Group and IHH Healthcare Berhad, which is listed in Malaysia and Singapore, and has operations in Turkey, India, China, and Europe. She is on the Board of Lendleases retirement living business, known as Keyton. Prior to returning to Australia in 2017, she was the Group CEO of the UKs private hospital group BMI Healthcare, and Group CEO of Ramsay Healthcare, UK.
|
Mrs Michelle McPherson | Deputy Chief Executive OfficerChief Financial Officer | Sep 2008 |
-
|
Ms Roslyn Toms | Group Executive - Legal and Chief Risk OfficerCompany Secretary | Apr 2013 |
-
|
Mr Jordan French | Senior Corporate CounselJoint Company Secretary | Aug 2017 |
-
|
Edward Close | Chief Executive - Australian Residents Health Insurance |
-
|
|
James Barr | Chief Executive - International Visitors |
-
|
|
Anna Gladman | Chief Executive - nib Travel |
-
|
|
Rob Hennin | Chief Executive Officer - nib New Zealand |
-
|
|
Michelle McPherson | Deputy Chief Executive OfficerChief Financial Officer |
-
|
|
Nick Freeman | Group Chief Financial Officer |
-
|
|
Brendan Mills | Group Chief Information Officer |
-
|
|
Matt Paterson | Group Chief Operations Officer |
-
|
|
Martin Adlington | Group Chief People Officer |
-
|
|
Roslyn Toms | Group Executive - Legal and Chief Risk Officer |
-
|
|
Roslyn Toms | Group Executive - Legal and Chief Risk OfficerCompany Secretary |
-
|
|
Jordan French | Senior Corporate CounselJoint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited (i) | 76,586,168 | 16.68% |
J P Morgan Nominees Australia Pty Limited | 39,689,066 | 8.64% |
Citicorp Nominees Pty Limited (i) | 36,500,150 | 7.95% |
Bnp Paribas Noms Pty Ltd | 15,080,080 | 3.28% |
National Nominees Limited | 14,976,468 | 3.26% |
BNP Paribas Nominees Pty Ltd (i) | 2,264,164 | 0.49% |
Citicorp Nominees Pty Limited (ii) | 1,789,169 | 0.39% |
Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd | 1,657,704 | 0.36% |
HSBC Custody Nominees (Australia) Limited (ii) | 1,536,118 | 0.33% |
Mr Mark Anthony Fitzgibbon | 1,095,501 | 0.24% |
BNP Paribas Nominees Pty Ltd (ii) | 981,705 | 0.21% |
Fitzy (Nsw) Pty Ltd | 874,621 | 0.19% |
Merrill Lynch (Australia) Nominees Pty Limited | 810,559 | 0.18% |
Powerwrap Limited | 714,819 | 0.16% |
Cpu Share Plans Pty Ltd (i) | 569,345 | 0.12% |
Netwealth Investments Limited | 489,174 | 0.11% |
Mrs Michelle Mcpherson | 467,911 | 0.10% |
Modane Pty Ltd | 459,744 | 0.10% |
Cpu Share Plans Pty Ltd (ii) | 444,147 | 0.10% |
Mr John Arthur Foyle Turner | 430,000 | 0.09% |